News

Bluma Wellness Inc. Sets Opening Date for Sixth ‘One Plant Florida’ Retail Dispensary and Delivery Hub in Avon Park, Florida

October 13, 2020

TORONTO–(BUSINESS WIRE)–Bluma Wellness Inc. (the “Company” or “Bluma Wellness”) (CSE:BWEL.U) is pleased to announce that its wholly-owned operating subsidiary, One Plant Florida, intends to open its sixth retail dispensary and delivery hub, located in Avon Park, Florida on or before Monday, October 19, 2020, subject to the receipt of all required regulatory approvals from the…

Details

Goldfinch Bio Announces Upcoming Presentation of Phase 1 Clinical Data for Lead Precision Kidney Therapeutic Candidate, GFB-887, and Expansion of Scientific Leadership Team

October 13, 2020

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced that it will present clinical data from a Phase 1 study of its lead precision kidney therapeutic candidate, GFB-887, at the American Society of Nephrology (ASN) Kidney Week 2020 Annual Meeting,…

Details

Schwazze, Formerly Operating as Medicine Man Technologies, Inc., Announces Upcoming Conference Participation

October 13, 2020

DENVER–(BUSINESS WIRE)–Schwazze, formerly operating as Medicine Man Technologies Inc. (OTCQX: SHWZ) (“Schwazze ” or “the Company”), today announced its participation in the Benzinga Cannabis Capital Conference on October 15, 2020. During the event, Chief Executive Officer Justin Dye will serve on a panel titled “Big CPG Cropping Up In Cannabis” at 2:00 p.m. ET. He…

Details

Cresco Labs to Report Third Quarter 2020 Financial Results on November 18th, 2020

October 13, 2020

CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report its financial results for the third quarter ended September 30th, 2020 on Wednesday, November 18th, 2020 before the market opens. The Company will host a conference call…

Details

Heritage Cannabis Holdings Subsidiary CannaCure Receives Sales License from Health Canada

October 13, 2020

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that its subsidiary CannaCure Corp. (“CannaCure”) has been granted a cannabis oil sales license by Health Canada, effective October 9, 2020. This sales license will allow CannaCure to begin selling cannabis products, including oil derivatives, directly to the…

Details

H1 2020 Insomnia Pipeline Review – ResearchAndMarkets.com

October 13, 2020

DUBLIN–(BUSINESS WIRE)–The “Insomnia – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Insomnia (Central Nervous System) pipeline landscape. Insomnia is a sleep disorder that is characterized by difficulty falling and/or staying asleep. Symptoms include difficulty falling asleep at night, irritability, depression or anxiety, tension…

Details

Global Plant Protein Business and Investment Analysis & Opportunities Report 2020: Product Strategy, Innovation and Brand Share Analysis, Competitive Landscape, Market Size – ResearchAndMarkets.com

October 13, 2020

DUBLIN–(BUSINESS WIRE)–The “Global Plant Protein Business and Investment Opportunities (2016-2025) Insight Series – White Space / Gap Analysis, Product Strategy, Innovation and Brand Share Analysis, Competitive Landscape, Market Size Across 50+ Segments – Updated in Q3, 2020” report has been added to ResearchAndMarkets.com’s offering. Globally, the plant-protein market has recorded strong growth in recent years.…

Details

Insights on Medical Marijuana Market within the Pharmaceuticals Sector | Increasing Production of Medical Marijuana to Emerge as a Key Driver | Technavio

October 12, 2020

LONDON–(BUSINESS WIRE)–The global medical marijuana market is expected to grow at a CAGR of over 24% during 2020-2024, according to the latest market research report by Technavio. The report provides a detailed analysis on the impact and new opportunities created by the COVID-19 pandemic. The report also helps clients keep up with new product launches…

Details

ROSEN, TOP RANKED INVESTOR COUNSEL, Reminds Aurora Cannabis Inc. Investors of Important Deadline in Securities Class Action – ACB

October 12, 2020

NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for…

Details

ACB SHAREHOLDER DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Aurora Cannabis Inc.

October 12, 2020

NEW YORK–(BUSINESS WIRE)–Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) between February 13, 2020…

Details

DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Against Aurora Cannabis, Inc. (ACB)

October 9, 2020

BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) securities between February 13, 2020 and September 4, 2020, inclusive (the “Class…

Details

ACB INVESTOR ALERT: Bernstein Liebhard Announces that a Securities Class Action Lawsuit has Been Filed Against Aurora Cannabis Inc.

October 9, 2020

NEW YORK–(BUSINESS WIRE)–Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) between February 13, 2020 and September 4, 2020 (the “Class Period”). The lawsuit filed in…

Details